Market Place
Sourcing Support
Metagenomi Therapeutics Reveals 2025 Financials And Business
05 Mar 2026 //
GLOBENEWSWIRE
Metagenomi Presents at 46th Annual TD Cowen Healthcare Conference
23 Feb 2026 //
GLOBENEWSWIRE
Metagenomi Rebrands as Metagenomi Therapeutics
12 Jan 2026 //
GLOBENEWSWIRE
Metagenomi To Present Preclinical Data On APOC3 Collaboration
01 Dec 2025 //
GLOBENEWSWIRE
Metagenomi To Present At Jefferies Healthcare Conference
17 Nov 2025 //
GLOBENEWSWIRE
Metagenomi Cuts 25% Staff as CEO Advances Hemophilia Therapy
12 Nov 2025 //
BIOSPACE
Metagenomi Reports Q3 2025 Financials, Prioritizes Pipeline
11 Nov 2025 //
GLOBENEWSWIRE
Metagenomi Shows Preclinical MGX-001 Data For Hemophilia A
11 Nov 2025 //
GLOBENEWSWIRE
Metagenomi`s Business Updates and Q2 2025 Financial Results
12 Aug 2025 //
GLOBENEWSWIRE
Metagenomi Adds Laurence Reid, PhD to Board of Directors
11 Aug 2025 //
GLOBENEWSWIRE
Metagenomi Shows Next-Gen Genome Editing at ASGCT 2025
14 May 2025 //
GLOBENEWSWIRE
Metagenomi Reports Business Updates and Q1 2025 Financial Results
13 May 2025 //
GLOBENEWSWIRE
Metagenomi to Present at Upcoming Scientific Meetings
02 May 2025 //
GLOBENEWSWIRE
Metagenomi Reports 2024 Financial Results
17 Mar 2025 //
GLOBENEWSWIRE
Metagenomi to Present at TD Cowen`s Annual Health Care Conference
11 Feb 2025 //
GLOBENEWSWIRE
Metagenomi Announces New Appointment to its Board of Directors
15 Jan 2025 //
GLOBENEWSWIRE
Metagenomi to Present at 43rd Annual J.P. Morgan Conference
08 Jan 2025 //
GLOBENEWSWIRE
Metagenomi Presents Genome Editing Tools At Nature Conference
11 Dec 2024 //
GLOBENEWSWIRE
Metagenomi Presents Hemophilia A Data at ASH 2024
09 Dec 2024 //
GLOBENEWSWIRE
Metagenomi Reports Business Updates & Q3 2024 Financial Results
13 Nov 2024 //
GLOBENEWSWIRE
Metagenomi Presents Preclinical Hemophilia A Data at ASH
05 Nov 2024 //
GLOBENEWSWIRE
Metagenomi Presents Novel Adenine Base Editors For Genome Editing
24 Oct 2024 //
GLOBENEWSWIRE
Metagenomi Presents Compact SMART Editing Platform at AIChE 7th
14 Oct 2024 //
GLOBENEWSWIRE
Metagenomi To Present At Chardan`s Genetic Medicines Event
19 Sep 2024 //
GLOBENEWSWIRE
Metagenomi Lead Hemophilia A Program Shows 12-Month Durable FVIII Levels
03 Sep 2024 //
GLOBENEWSWIRE
Metagenomi Presents AI-Enabled SMART Editing Advancements at CRISPR Conference
29 Aug 2024 //
GLOBENEWSWIRE
Metagenomi to Participate in Upcoming Investor Conferences
28 Aug 2024 //
GLOBENEWSWIRE
Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results
14 Aug 2024 //
GLOBENEWSWIRE
Gene editing biotech Metagenomi plans modest $87M IPO
05 Feb 2024 //
FIERCE BIOTECH
Metagenomi submits IPO paperwork in third planned biotech listing of 2024
05 Jan 2024 //
ENDPTS
Metagenomi Presents New Data on Novel Gene Editing Systems at ASGCT
19 May 2023 //
BUSINESSWIRE
Metagenomi to Present at 41st Annual J.P. Morgan Healthcare Conference
03 Jan 2023 //
BUSINESSWIRE
